Paula Ragan - 15 Jun 2021 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Role: President and CEO, Director
Signature: /s/ Derek M. Meisner, attorney-in-fact
Issuer symbol: XFOR
Transactions as of: 15 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 17 Jun 2021, 17:12:18 UTC
Previous filing: 02 Jun 2021
Next filing: 25 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XFOR	Common Stock	Award	$0	+44,826	+11%	$0.000000	451,074	15 Jun 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units issued to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer and has no expiration date. One third of the shares underlying the restricted stock unit award vested on June 15, 2021. One third of the shares will vest on June 15, 2022, and one third of the shares will vest on June 15, 2023, subject to the Reporting Person providing continuous service to the Issuer on such dates. Shares in respect of the vested portion of the award must be delivered no later than March 15 of the calendar year following the year in which vesting occurs.
F2	Of the shares of common stock reported, 262,246 shares represent unvested restricted stock units.

Content

Represents restricted stock units issued to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer and has no expiration date. One third of the shares underlying the restricted stock unit award vested on June 15, 2021. One third of the shares will vest on June 15, 2022, and one third of the shares will vest on June 15, 2023, subject to the Reporting Person providing continuous service to the Issuer on such dates. Shares in respect of the vested portion of the award must be delivered no later than March 15 of the calendar year following the year in which vesting occurs.

Of the shares of common stock reported, 262,246 shares represent unvested restricted stock units.